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Do Self-Management Interventions Work in Patients With Heart Failure?
An Individual Patient Data Meta-Analysis
Abstract
BACKGROUND: Self-management interventions are widely implemented in the care for patients with heart
failure (HF). However, trials show inconsistent results, and whether specific patient groups respond
differently is unknown. This individual patient data meta-analysis assessed the effectiveness of self-
management interventions in patients with HF and whether subgroups of patients respond differently.
METHODS AND RESULTS: A systematic literature search identified randomized trials of self-management
interventions. Data from 20 studies, representing 5624 patients, were included and analyzed with the use of
mixed-effects models and Cox proportional-hazard models, including interaction terms. Self-management
interventions reduced the risk of time to the combined end point of HF-related hospitalization or all-cause
death (hazard ratio, 0.80; 95% confidence interval [CI], 0.71-0.89), time to HF-related hospitalization
(hazard ratio, 0.80; 95% CI, 0.69-0.92), and improved 12-month HF-related quality of life (standardized
mean difference, 0.15; 95% CI, 0.00-0.30). Subgroup analysis revealed a protective effect of self-management
on the number of HF-related hospital days in patients(mean, 0.70 versus 5.35 days; interaction P=0.03).
Patients without depression did not show an effect of self-management on survival (hazard ratio for all-cause
mortality, 0.86; 95% CI, 0.69-1.06), whereas in patients with moderate/severe depression, self-management
reduced survival (hazard ratio, 1.39; 95% CI, 1.06-1.83, interaction P=0.01).
CONCLUSIONS: This study shows that self-management interventions had a beneficial effect on time to
HF-related hospitalization or all-cause death and HF-related hospitalization alone and elicited a small increase
in HF-related quality of life. The findings do not endorse limiting self-management interventions to subgroups
of patients with HF, but increased mortality in depressed patients warrants caution in applying self-
management strategies in these patients.
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Abstract
Background—Self-management interventions are widely implemented in care for patients with 
heart failure (HF). Trials however show inconsistent results and whether specific patient groups 
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respond differently is unknown. This individual patient data meta-analysis assessed the 
effectiveness of self-management interventions in HF patients and whether subgroups of patients 
respond differently.
Methods and Results—Systematic literature search identified randomized trials of self-
management interventions. Data of twenty studies, representing 5624 patients, were included and 
analyzed using mixed effects models and Cox proportional-hazard models including interaction 
terms. Self-management interventions reduced risk of time to the combined endpoint HF-related 
hospitalization or all-cause death (hazard ratio [HR], 0.80; 95% confidence interval [CI], 0.71–
0.89), time to HF-related hospitalization (HR, 0.80; 95%CI, 0.69–0.92), and improved 12-month 
HF-related quality of life (standardized mean difference 0.15; 95%CI, 0.00–0.30). Subgroup 
analysis revealed a protective effect of self-management on number of HF-related hospital days in 
patients <65 years (mean number of days 0.70 days vs. 5.35 days; interaction p=0.03). Patients 
without depression did not show an effect of self-management on survival (HR for all-cause 
mortality, 0.86; 95%CI, 0.69–1.06), while in patients with moderate/severe depression self-
management reduced survival (HR, 1.39; 95%CI, 1.06–1.83, interaction p=0.01).
Conclusions—This study shows that self-management interventions had a beneficial effect on 
time to HF-related hospitalization or all-cause death, HF-related hospitalization alone, and elicited 
a small increase in HF-related quality of life. The findings do not endorse limiting self-
management interventions to subgroups of HF patients, but increased mortality in depressed 
patients warrants caution in applying self-management strategies in these patients.
Keywords
heart failure; individual patient data meta-analysis; self-management; subgroup analysis
Heart failure (HF) is one of the most prevalent chronic conditions1 and despite advances in 
medical treatment, patients diagnosed with HF face an increased risk of hospitalization and 
mortality.2 The impact of HF on patients’ lives is substantial, as they are expected to adhere 
daily to drug treatment, lifestyle changes and monitoring of signs and symptoms to prevent 
decompensation.3 Self-management interventions, which aim at improving patients’ 
knowledge and skills to perform those behaviors and manage their condition, have received 
increasing attention in care for patients with HF.
A meta-analysis on the effects of self-management interventions in patients with HF showed 
significant reductions of all-cause and HF-related hospitalization in patients receiving the 
self-management intervention, although there were no effects on mortality and quality of life 
(QoL).4 A more recent systematic review, however, emphasized the heterogeneous findings 
across studies.5 Several recently conducted large randomized controlled trials (RCTs) were 
unable to show beneficial effects of self-management interventions on mortality or 
hospitalization rates,6–9 further illustrating heterogeneity in observed effects.
Part of this heterogeneity may be attributable to varying trial designs, intervention 
components, follow-up periods, or outcome assessments. Since individual RCTs included 
different groups of patients, variations in patient characteristics are another likely source of 
heterogeneity. Specific subgroups of patients might benefit more, or even might not benefit, 
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from self-management interventions. Such knowledge will contribute to targeting self-
management interventions to those groups anticipated to benefit most, which may become 
indispensable in times of decreasing resources.
Sample sizes in individual trials are generally too small to identify factors modifying the 
success of self-management interventions. By combining data from multiple trials, 
individual patient data (IPD) meta-analysis allows a reliable identification of patient 
subgroups with a differential treatment response. Furthermore, IPD meta-analysis enables a 
uniform definition of subgroups across studies, uniform imputation of missing data and 
statistical analysis, and analysis of unreported endpoints.10 Additionally, the main effects of 
included self-management interventions can be pooled and analyzed in a uniform manner.
This IPD meta-analysis aimed to evaluate effectiveness of self-management interventions 
regarding HF-related or generic quality of life, HF-related or all-cause hospitalization, and 
all-cause mortality and to identify subgroups of patients with HF that respond differently to 
such interventions.
Methods
Data Sources and Study Selection
The electronic databases of PubMed, EMBASE, CENTRAL, PsycINFO and CINAHL were 
searched from January 1985 through June 2013, as well as reference lists of systematic 
reviews.
Studies were included if they (1) met the definition of self-management intervention, (2) had 
a RCT design, (3) included patients with an established diagnosis of HF, (4) compared the 
self-management intervention to usual care or another self-management intervention, (5) 
reported data on one or more of the selected outcomes, (6) followed patients for at least six 
months, and (7) were reported in English, Dutch, French, German, Italian, Portuguese, or 
Spanish. Self-management interventions were defined as interventions providing 
information to patients and minimally two of the following components: (1) stimulation of 
sign/symptom monitoring, (2) education in problem solving skills, and enhancement of (3) 
medical treatment adherence, (4) physical activity, (5) dietary intake, or (6) smoking 
cessation. Studies were independently assessed by two researchers (NHJ and HW) on risk of 
bias (low/unclear/high) using three criteria based on the ‘Risk of bias’ tool from the 
Cochrane Collaboration11: (1) random concealed allocation to treatment, (2) intention-to-
treat analysis, and (3) other deviances (e.g., high drop-out, imbalances between groups). Any 
discrepancies were solved through consensus with a third researcher (JCAT). Studies scoring 
a high risk of bias on one or more criteria used from the ‘Risk of bias’ tool11 were defined as 
‘high risk of bias’. Those studies were included in the analysis, but the impact of studies of 
lower methodological quality was assessed in a sensitivity analysis by excluding these 
studies.
Data collection
The principal investigators of selected studies were invited to participate in this IPD meta-
analysis and share their de-individualized raw trial data. For details on the search syntax, 
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collaboration with principal investigators, and a list of all requested variables, we refer to the 
study protocol.12 Data from each trial were checked on range, extreme values, internal 
consistency, missing values, and consistency with published reports. When recoding of 
categorical variables was needed to create uniform categories, principal investigators were 
consulted to ensure correct interpretation of variables. This IPD meta-analysis is exempt 
from formal approval by the Medical Research Ethics Committee of University Medical 
Center Utrecht, since it re-analyzes de-identified data from trials in which informed consent 
has been obtained by principal investigators.
Outcomes
This study focused in the analysis on 8 main outcomes, divided into HF-related outcomes 
and general outcomes. HF-related outcomes were time to the combined endpoint of HF-
related hospitalization or all-cause death, time to first HF-related hospitalization, total days 
of HF-related hospital stay at 12 months, and HF-related quality of life (HF-QoL) at 12 
months (measured with Heart Failure Symptom Scale,13 Kansas City Cardiomyopathy 
Questionnaire,14 MacNew Heart Disease Health-related Quality of Life Instrument,15 or 
Minnesota Living With Heart Failure Questionnaire16). General outcomes were generic QoL 
at 12 months (measured with Short Form Health Survey 1217 or 3618), time to all-cause 
death, time to first all-cause hospitalization, and total days of all-cause hospital stay at 12 
months. In addition, outcomes at 6 months and binary outcomes for mortality and 
hospitalization at 6 and 12 months were collected and analyzed, but are presented in 
Supplemental Tables 1 and 2 as subordinate outcomes.
Patient-specific effect modifiers
Clinically relevant potential effect modifiers (i.e., variables, such as sex or age, that modify 
the effect of self-management interventions) were selected based on the self-management 
literature in HF patients19 and availability of comparable data across trials. The selected 
patient characteristics are presented along with the baseline data in Table 1. We assumed that 
these characteristics could modify the effect of interventions; e.g., self-management 
interventions might be more effective in patients with only primary education compared to 
higher educated patients.
Statistical analyses
Principal investigators were involved in designing a detailed plan for the statistical analysis 
and agreed upon this prior to data analysis (see Supplemental Methods for detailed statistical 
plan). Data from individual studies were merged to create one database. Using multiple 
imputation by chained equations (25 imputations),21 missing values for baseline variables 
and outcomes were imputed within studies. The imputed datasets were analyzed using a 
one-stage approach (i.e., simultaneously analyzing all observations while accounting for 
clustering of observations within studies).22 Results of imputed datasets were pooled using 
Rubin’s rules and presented as the primary results.23
All analyses were performed according to the intention-to-treat principle. For time-to-event 
endpoints, effects of self-management were quantified by estimating hazard ratios (HR) 
using Cox proportional-hazard models, including a frailty term to account for clustering 
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within studies. The continuous outcomes (HF-QoL and generic QoL) were quantified by 
standardized mean differences (SMD) between intervention arms and analyzed using linear 
mixed effects models. To correctly model the presence of overdispersion in count data of 
total days of hospital stay, negative binomial mixed effects models were used to estimate 
relative length of stay. Binary outcome data (all-cause mortality, all-cause, and HF-related 
hospitalization) were analyzed with log-binomial mixed effects models, which estimated 
risk ratios (RR). In case of non-convergence of a model, odds ratios (OR) were estimated 
using a logistic mixed effects model, which is an addition to the published protocol.12 All 
mixed effects models included a random intercept and random slope for the treatment effect 
to take clustering within studies into account.
To assess whether the effect of self-management was modified by patient characteristics, the 
aforementioned models were extended with interaction terms for categorical patient 
characteristics included in Table 1. This was performed for each characteristic separately. If 
there were two or more effect modifiers with p<0.10 for the interaction (likelihood ratio 
test), the interaction terms were included in a multivariable model to estimate the effect of 
self-management within subgroups independent of other relevant effect modifiers. Effect 
modification was considered significant if the interaction term showed p<0.05 in the final 
model.
As a sensitivity analysis, we investigated potential retrieval bias (i.e., selective inclusion of 
studies in the IPD meta-analysis). Published main effects of studies for which we could not 
obtain the original data (and thus were not included in the IPD meta-analysis) were pooled 
in a random effects meta-analysis, together with the main effects of included studies. We 
repeated the main effects analysis by excluding the studies with enhanced usual care. To 
assess the impact of studies of lower methodological quality, a sensitivity analysis was 
performed excluding studies with a high risk of bias. Three additional sensitivity analyses 
assessed the robustness of the effect modifier analysis: (1) complete-case analysis to assess 
the effect of imputing data, (2) analyses restricted to newer studies (recruitment since 2000), 
and (3) excluding studies one-by-one to assess if the observed subgroup effects are 
attributable to a specific study. All analyses were done in R for Windows version 3.1.1 (R 
Development Core Team, Vienna).
Results
Thirty-two studies (n=8737) met the inclusion criteria and principal investigators were 
approached to participate in this IPD meta-analysis. The investigators of five studies could 
not be contacted, IPD of three studies were no longer available, and investigators of four 
studies were not willing to participate. This resulted in inclusion of data of 20 RCTs, 
representing 5624 patients in total.
Patient characteristics for which baseline data were available are presented in Table 1. A 
majority of patients was male (57.2%) and mean age was 69.7 years (SD 12.4). Mean left-
ventricular ejection fraction (LVEF) was 39.2% (SD 18.2) and 26.0% of patients had a 
preserved ejection fraction (≥50%). Median time since diagnosis of HF was 1.6 years (IQR 
0.1–5.4). Baseline characteristics of patients included in this IPD meta-analysis were similar 
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to those of patients in eligible studies that did not provide original data, except for the 
percentage males and current smokers (resp. 63.8% and 11.2% in non-participating studies).
Characteristics of included studies are presented in Table 2. Sample size ranged from 4231 to 
1023 patients.7 The majority of interventions were delivered by a specialized nurse, two 
interventions used a group approach,29,39 and two interventions consisted of telephonic case 
management.36,37 One trial included two intervention arms.7 Duration of the interventions 
ranged from 0.525,30 to 187 months. Two studies provided “enhanced care” to the control 
patients,6,29 consisting of some educational components. These components were judged 
marginal and in line with the education delivered to HF patients in usual care. Consequently, 
these two studies were included in the analysis.
Main effects of self-management interventions
Self-management interventions showed significant effects on several HF-related outcomes 
(Table 3). Interventions reduced risk of time to the combined endpoint of HF-related 
hospitalization or all-cause death (HR, 0.80; 95% confidence interval [CI], 0.71–0.89) and 
time to HF-related hospitalization alone (HR, 0.80; 95% CI, 0.69–0.92). There was a small 
improvement in HF-QoL at 12 months in patients receiving the intervention (SMD, 0.15; 
95% CI, 0.00–0.30). No effects were found for total days in hospital due to HF readmissions 
or any of the general outcomes. Figure 1 shows the effects across studies for HF-QoL, HF-
related hospitalization, and all-cause mortality.
Effects in patient subgroups
In the HF-related outcomes, subgroup analysis revealed significant effect modification by 
age on days in hospital due to HF (Table 3). For younger patients (<65 years), mean number 
of days in hospital due to HF in the intervention group was 0.70 days, while this was 
5.35days in the control group (relative length of stay, 0.09; 95% CI, 0.02–0.38). This 
difference was not found in patients aged 65–80 years (3.30 days in intervention group vs. 
3.84 days in control group, interaction p=0.03). For general outcomes (Table 3), there was 
significant effect modification by comorbid depression on time to all-cause death. While no 
significant effect of self-management was found in patients with no/mild depression on all-
cause death (HR, 0.86; 95% CI, 0.69–1.06), there was a negative effect in patients with 
moderate/severe depression on all-cause death (HR, 1.39; 95% CI, 1.06–1.83, interaction 
p=0.01). In univariable analysis, level of education showed significant effect modification on 
time to first all-cause hospitalization with lower educated patients showing a positive effect 
of the self-management intervention (HR, 0.82; 95% CI, 0.71–0.96, Supplemental Table 3), 
while there was no effect in patients who had completed secondary education (HR, 0.98; 
95% CI, 0.82–1.17), or higher education (HR, 1.26; 95% CI, 0.99–1.60; interaction p=0.02). 
After adjustment for potential effect modification by age, effect modification by level of 
education was no longer significant (interaction p=0.07). Additional analyses of outcomes 
measured at 6 months did not yield different insights (Supplemental Tables 1 and 2).
Sensitivity analyses
Including published effects of eligible studies for which original data could be obtained, did 
not change the primary findings (Supplemental Table 4), neither did the sensitivity analysis 
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of excluding studies with enhanced usual care (Supplemental Table 5). The other sensitivity 
analyses also yielded similar effects. Only when subgroup analysis was repeated without the 
trial by Jaarsma and colleagues,7 effect modification by depression on time to all-cause 
death was no longer statistically significant (interaction p=0.22) and the negative effect for 
patients with moderate/severe depression on all-cause death was no longer present (HR, 
0.63, 95% CI, 0.29–1.34).
Discussion
To our knowledge, this study is the first IPD meta-analysis including sufficiently large 
numbers of HF patients to be able to identify subgroups of patients that respond differently 
to self-management interventions. We observed protective effects of self-management 
interventions on time to the combined endpoint of HF-related hospitalization or all-cause 
death, HF-related hospitalization alone and HF-QoL. Subgroup analyses showed that 
younger patients responded better to self-management in terms of reduced total days of HF-
related hospitalization, and that HF patients with depression showed a reduced survival 
following the self-management intervention.
The beneficial effects found on time to the combined endpoint of HF-related hospitalization 
or all-cause death and on HF-related hospitalization alone have also been reported by 
previous (aggregate data) meta-analyses on similar interventions.4,42 Earlier systematic 
reviews consistently stressed the large heterogeneity across studies regarding effects of self-
management on health-related QoL.5 Our study included several recent large neutral trials6,7 
and was the first to pool the results for HF-QoL and compute an overall effect. Although 
95% confidence intervals were rather wide, we observed a small positive effect for HF-QoL 
at 12 months. In contrast to HF-related outcomes, we found no effects of self-management 
interventions on general outcomes (i.e., generic QoL, all-cause mortality, all-cause 
hospitalization). This is in line with previous meta-analyses.4,42 Thus, it seems that self-
management interventions are particularly effective in HF patients for improving outcomes 
directly related to their disease.
The subgroup analysis showed that younger patients (<65 years) benefited more from self-
management interventions than older patients. Younger patients in intervention groups were 
discharged sooner from hospitalization for HF during follow-up than their counterparts in 
control groups. There was no intervention effect in older patients. Older hospitalized patients 
have an increased risk of functional decline, cognitive dysfunction and generally suffer from 
more comorbid conditions, complicating their overall functioning and recovery time once 
hospitalized.43 Especially older persons are at high risk in the period after hospitalization 
due to deprived sleep, poor nutrition, stress, symptoms, new treatments, and inactivity. 
Equipping patients with self-management skills might not be sufficient in such complex 
situations. Post-discharge instability may need new approaches not only targeting HF itself 
for a safer transition from hospital to home.44 Still, the effect modification by age was not 
consistent across other health outcomes studied and the number of patients aged <65 
included in the analysis was relatively small (n=139). The findings should therefore be 
considered hypothesis-generating.
Jonkman et al. Page 7
Circulation. Author manuscript; available in PMC 2017 March 22.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Self-management interventions increased the risk of all-cause mortality in patients with 
moderate/severe depression. Sensitivity analyses indicated that this effect was driven by the 
largest study included in this IPD meta-analysis.7 The authors of that study reported a 
similar trend of their intervention for patients with depressive symptoms in their subgroup 
analysis.45 These findings question the suitability of generic self-management interventions 
in HF patients with depressive symptoms. Depression is often associated with reduced 
motivation, which might compromise adherence to medication regimen and lifestyle 
changes,46 particularly if multiple comorbid conditions (and treatment) need to be self-
managed. These patients may be burdened with self-managing their HF. Increased mortality 
following self-management interventions might therefore be caused by suboptimal 
(self-)management of their illnesses, including HF. Interestingly, the negative effect was 
limited to all-cause mortality. In the five studies that measured depression, self-management 
interventions showed an overall HR of 0.95 on time to HF-related hospitalization (95% CI, 
0.94–0.97) and subgroup analysis did not reveal a differential treatment effect between 
patients with and without depression (HR depression, 1.00; 95% CI, 0.74–1.35; HR without 
depression, 0.92; 95% CI, 0.71–1.18; interaction p=0.64). With no clear explanation for 
reduced survival in HF patients with depression, caution is warranted before applying self-
management strategies in care for those patients. Patients with depressive symptoms might 
need additional psychological interventions or medication before initiating self-management 
interventions.47 Screening HF patients on symptoms of depression might help to determine 
to what extent attention should be paid to self-management skills or additional psychological 
interventions in the treatment plan.
Previous subgroup analyses in three large RCTs have shown that self-management 
interventions might be more effective for patients with low socio-economic status. DeWalt 
and colleagues found that only patients with low literacy showed a positive effect on HF-
related hospitalizations after self-management support.6 A Dutch self-management trial 
found greatest improvements in health-related QoL in patients with lower education.48 The 
third trial showed that patients with reduced income benefitted most from self-management.8 
The pattern across studies generates the hypothesis that patients with a lower socio-
economic status may benefit most from self-management interventions. Similarly, our 
analyses indicate a protective effect of self-management on time to first all-cause 
hospitalization in patients with lower education. However, after adjusting for other potential 
effect modifiers, this effect did not reach statistical significance.
This IPD meta-analysis was one of the first attempts to pool individual patient data on self-
management interventions for patients with HF. The study included sufficient patients 
(n=5624) to analyze treatment effects in patient subgroups and applied robust statistical 
modelling according to a pre-specified plan. Reported effects were found across cultures and 
healthcare settings. Nevertheless, this study has several limitations that deserve further 
discussion. First, despite numerous efforts to reach all principal investigators, we were 
unable to include all 32 eligible trials. Inclusion of 62.5% (20/32) of eligible trials is 
relatively high compared to IPD meta-analyses on similar interventions.49 Including 
published results of trials for which no IPD were available did not change main effects, but 
this could not be checked for the subgroup analysis due to limited published subgroup data. 
Second, included self-management interventions differed in terms of intensity, duration, 
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mode, and content. Although reported effects were found for self-management interventions 
in any setting, specific types of interventions might work better for specific subgroups of 
patients. Addressing the question “what works for whom?” deserves attention in subsequent 
research. Third, this IPD meta-analysis was highly dependent on data previously collected in 
individual studies which limited choice of potential effect modifiers to be studied. Individual 
trials indicated that self-management interventions might be more effective in non-adherers 
to regimens25 or in patients with better cognitive status.48 We could not analyze those 
potential effect modifiers, since variables were not collected in all studies. If uniform 
standards for baseline variables were established, a meaningful comparison of patient 
subgroups across studies may provide further insight into patient characteristics modifying 
treatment effects. Finally, although all (subgroup) analyses were pre-planned and 
documented in our protocol,12 their large number increases the risk of false-positive 
findings. Our subgroup analysis was exploratory in nature and not intended to demonstrate 
causal mechanisms. Causal mechanisms of subgroup effects need to be completely 
understood before any final conclusions can be drawn. Validation of our findings in large 
trial databases may confirm our subgroup findings.
Conclusion
We found that despite diversity in intensity, content, and personnel delivering the 
intervention, self-management interventions in patients with HF improve outcomes directly 
related to their disease. Although self-management interventions might be more effective in 
younger patients in reducing length of hospital stay, we did not observe consistent subgroup 
effects across different health outcomes. This study does not endorse limiting self-
management interventions to specific subgroups of HF patients, but increased mortality in 
depressed patients warrants caution in applying self-management strategies in these patients.
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Acknowledgments
Funding Sources: This work was supported by The Netherlands Organisation for Health Research and 
Development, ZonMw (grant number 520001002).
FA is in the advisory board of Medtronic, Sorin. DAD reports grants from NIH during the conduct of the study, 
outside the submitted work. MH reports grants from MDRTC during the conduct of the study, outside the submitted 
work. RTT reports grants from Merck Canada Inc., AstraZeneca Canada, and personal fees from Merck Canada 
Inc., outside the submitted work.
References
1. Ambrosy AP, Fonarow GC, Butler J, Chionel O, Greene SJ, Vaduganathan M, Nodari S, Lam CSP, 
Sato N, Shah AN, Gheorghiade M. The global health and economic burden of hospitalizations for 
heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014; 
63:1123–1133. [PubMed: 24491689] 
2. Curtis LH, Greiner MA, Hammill BG, Kramer JM, Whellan DJ, Schulman KA, Hernandez AF. 
Early and long-term outcomes of heart failure in elderly persons, 2001–2005. Arch Intern Med. 
2008; 168:2481–2488. [PubMed: 19064833] 
Jonkman et al. Page 9
Circulation. Author manuscript; available in PMC 2017 March 22.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
3. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, 
Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM. 
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in 
the Adult: a report of the American College of Cardiology/American Heart Association Task Force 
on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and 
Management of Heart Failure). Circulation. 2005; 112:e154–e235. [PubMed: 16160202] 
4. Jovicic A, Holroyd-Leduc JM, Straus SE. Effects of self-management intervention on health 
outcomes of patients with heart failure: a systematic review of randomized controlled trials. BMC 
Cardiovasc Disord. 2006; 6:43. [PubMed: 17081306] 
5. Ditewig JB, Blok H, Havers J, van Veenendaal H. Effectiveness of self-management interventions 
on mortality, hospital readmissions, chronic heart failure hospitalization rate and quality of life in 
patients with chronic heart failure: a systematic review. Patient Educ Couns. 2010; 78:297–315. 
[PubMed: 20202778] 
6. DeWalt DA, Schillinger D, Ruo B, Bibbins-Domingo K, Baker DW, Holmes GM, Weinberger M, 
abasco-O'Connell A, Broucksou K, Hawk V, Grady KL, Erman B, Sueta CA, Chang PP, Cene CW, 
Wu JR, Jones CD, Pignone M. Multisite randomized trial of a single-session versus multisession 
literacy-sensitive self-care intervention for patients with heart failure. Circulation. 2012; 125:2854–
2862. [PubMed: 22572916] 
7. Jaarsma T, van der Wal MH, Lesman-Leegte I, Luttik ML, Hogenhuis J, Veeger NJ, Sanderman R, 
Hoes AW, van Gilst WH, Lok DJ, Dunselman PH, Tijssen JG, Hillege HL, van Veldhuisen DJ. 
Effect of moderate or intensive disease management program on outcome in patients with heart 
failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart 
Failure(COACH). Arch Intern Med. 2008; 168:316–324. [PubMed: 18268174] 
8. Powell LH, Calvin JE Jr, Richardson D, Janssen I, Mendes de Leon CF, Flynn KJ, Grady KL, 
Rucker-Whitaker CS, Eaton C, Avery E. Self-management counseling in patients with heart failure: 
the heart failure adherence and retention randomized behavioral trial. JAMA. 2010; 304:1331–1338. 
[PubMed: 20858878] 
9. Dracup K, Moser DK, Pelter MM, Nesbitt TS, Southard J, Paul SM, Robinson S, Cooper LS. 
Randomized, controlled trial to improve self-care in patients with heart failure living in rural areas. 
Circulation. 2014; 130:256–264. [PubMed: 24815499] 
10. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, 
conduct, and reporting. BMJ. 2010; 340:c221. [PubMed: 20139215] 
11. Higgins, JPT.; Green, S. Cochrane Handbook for Systematic Reviews of Interventions, version 
5.1.0. The Cochrane Collaboration; 2011. 
12. Jonkman NH, Westland H, Trappenburg JC, Groenwold RHH, Effing-Tijdhof TW, Troosters T, van 
der Palen J, Bourbeau J, Jaarsma T, Hoes AW, Schuurmans MJ. Towards tailoring of self-
management for patients with chronic heart failure or chronic obstructive pulmonary disease: a 
protocol for an individual patient data meta-analysis. BMJ Open. 2014; 4:e005220.
13. Baker DW, Brown J, Chan KS, Dracup KA, Keeler EB. A telephone survey to measure 
communication, education, self-management, and health status for patients with heart failure: the 
Improving Chronic Illness Care Evaluation(ICICE). J Card Fail. 2005; 11:36–42. [PubMed: 
15704062] 
14. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City 
Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 
2000; 35:1245–1255. [PubMed: 10758967] 
15. Hofer S, Lim L, Guyatt G, Oldridge N. The MacNew Heart Disease health-related quality of life 
instrument: a summary. Health Qual Life Outcomes. 2004; 2:3. [PubMed: 14713315] 
16. Rector TS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure. Part 2: 
content, reliability and validity of a new measure, the Minnesota Living with Heart Failure 
Questionnaire. Heart Failure. 1987; 3:198–209.
17. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and 
preliminary tests of reliability and validity. Med Care. 1996; 34:220–233. [PubMed: 8628042] 
18. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey(SF-36). I. Conceptual 
framework and item selection. Med Care. 1992; 30:473–483. [PubMed: 1593914] 
Jonkman et al. Page 10
Circulation. Author manuscript; available in PMC 2017 March 22.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
19. Bos-Touwen I, Jonkman N, Westland H, Schuurmans M, Rutten F, de Wit N, Trappenburg J. 
Tailoring of self-management interventions in patients with heart failure. Curr Heart Fail Rep. 
2015; 12:223–235. [PubMed: 25929690] 
20. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968; 16:622–626. 
[PubMed: 5646906] 
21. Groothuis-Oudshoorn K, van Buuren S. MICE: Multivariate Imputation by Chained Equations in 
R. Journal of Statistical Software. 2011; 45
22. Simmonds MC, Higgins JP, Stewart LA, Tierney JF, Clarke MJ, Thompson SG. Meta-analysis of 
individual patient data from randomized trials: a review of methods used in practice. Clin Trials. 
2005; 2:209–217. [PubMed: 16279144] 
23. Rubin, DB. Multiple imputation for non-response in surveys. New York: John Wiley & Sons; 1987. 
24. Agren S, Evangelista LS, Hjelm C, Stromberg A. Dyads affected by chronic heart failure: a 
randomized study evaluating effects of education and psychosocial support to patients with heart 
failure and their partners. J Card Fail. 2012; 18:359–366. [PubMed: 22555264] 
25. Aldamiz-Echevarría I, Muñiz J, Rodríguez-Fernández JA, Vidán-Martínez L, Silva-César M, 
Lamelo-Alfonsín F, Díaz-Díaz JL, Ramos-Polledo V, Castro-Beiras A. Randomized controlled 
clinical trial of a home care unit intervention to reduce readmission and death rates in patients 
discharged from hospital following admission for heart failure. Revista española de cardiología. 
2007; 60:914–922. [PubMed: 17915147] 
26. Atienza F, Anguita M, Martinez-Alzamora N, Osca J, Ojeda S, Almenar L, Ridocci F, Valles F, de 
Velasco JA. Multicenter randomized trial of a comprehensive hospital discharge and outpatient 
heart failure management program. Eur J Heart Fail. 2004; 6:643–652. [PubMed: 15302014] 
27. Blue L, Lang E, McMurray JJ, Davie AP, McDonagh TA, Murdoch DR, Petrie MC, Connolly E, 
Norrie J, Round CE, Ford I, Morrison CE. Randomised controlled trial of specialist nurse 
intervention in heart failure. BMJ. 2001; 323:715–718. [PubMed: 11576977] 
28. Bruggink-Andre de la Porte PW, Lok DJ, van Veldhuisen DJ, van Wijngaarden J, Cornel JH, 
Zuithoff NPA, Badings E, Hoes AW. Added value of a physician-and-nurse-directed heart failure 
clinic: results from the Deventer–Alkmaar heart failure study. Heart. 2007; 93:819–825. [PubMed: 
17065182] 
29. Heisler M, Halasyamani L, Cowen ME, Davis MD, Resnicow K, Strawderman RL, Choi H, Mase 
R, Piette JD. A Randomized Controlled Effectiveness Trial of Reciprocal Peer Support in Heart 
Failure. Circ Heart Fail. 2013; 6:246–253. [PubMed: 23388114] 
30. Jaarsma T, Halfens R, Huijer Abu-Saad H, Dracup K, Gorgels T, van Ree J, Stappers J. Effects of 
education and support on self-care and resource utilization in patients with heart failure. Eur Heart 
J. 1999; 20:673–682. [PubMed: 10208788] 
31. Leventhal ME, Denhaerynck K, Brunner-La Rocca HP, Burnand B, Conca-Zeller A, Bernasconi 
AT, Mahrer-Imhof R, Froelicher ES, De Geest S. Swiss Interdisciplinary Management Programme 
for Heart Failure (SWIM-HF): a randomised controlled trial study of an outpatient inter-
professional management programme for heart failure patients in Switzerland. Swiss Med Wkly. 
2011; 141:w13171. [PubMed: 21384285] 
32. Martensson J, Stromberg A, Dahlstrom U, Karlsson JE, Fridlund B. Patients with heart failure in 
primary health care: effects of a nurse-led intervention on health-related quality of life and 
depression. Eur J Heart Fail. 2005; 7:393–403. [PubMed: 15718180] 
33. Otsu H, Moriyama M. Effectiveness of an educational self-management program for outpatients 
with chronic heart failure. Jpn J Nurs Sci. 2011; 8:140–152. [PubMed: 22117578] 
34. Peters-Klimm F, Campbell S, Hermann K, Kunz CU, Muller-Tasch T, Szecsenyi J. Case 
management for patients with chronic systolic heart failure in primary care: the HICMan 
exploratory randomised controlled trial. Trials. 2010; 11:56. [PubMed: 20478035] 
35. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary 
intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J 
Med. 1995; 333:1190–1195. [PubMed: 7565975] 
36. Riegel B, Carlson B, Kopp Z, LePetri B, Glaser D, Unger A. Effect of a standardized nurse case-
management telephone intervention on resource use in patients with chronic heart failure. Arch 
Intern Med. 2002; 162:705–712. [PubMed: 11911726] 
Jonkman et al. Page 11
Circulation. Author manuscript; available in PMC 2017 March 22.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
37. Riegel B, Carlson B, Glaser D, Romero T. Randomized controlled trial of telephone case 
management in Hispanics of Mexican origin with heart failure. J Card Fail. 2006; 12:211–219. 
[PubMed: 16624687] 
38. Sisk JE, Hebert PL, Horowitz CR, McLaughlin MA, Wang JJ, Chassin MR. Effects of nurse 
management on the quality of heart failure care in minority communities: a randomized trial. Ann 
Intern Med. 2006; 145:273–283. [PubMed: 16908918] 
39. Smeulders ES, van Haastregt JC, Ambergen T, Janssen-Boyne JJ, van Eijk JT, Kempen GI. The 
impact of a self-management group programme on health behaviour and healthcare utilization 
among congestive heart failure patients. Eur J Heart Fail. 2009; 11:609–616. [PubMed: 19359326] 
40. Stromberg A, Martensson J, Fridlund B, Levin LA, Karlsson JE, Dahlstrom U. Nurse-led heart 
failure clinics improve survival and self-care behaviour in patients with heart failure: results from a 
prospective, randomised trial. Eur Heart J. 2003; 24:1014–1023. [PubMed: 12788301] 
41. Tsuyuki RT, Fradette M, Johnson JA, Bungard TJ, Eurich DT, Ashton T, Gordon W, Ikuta R, 
Kornder J, Mackay E, Manyari D, O'Reilly K, Semchuk W. A multicenter disease management 
program for hospitalized patients with heart failure. J Card Fail. 2004; 10:473–480. [PubMed: 
15599837] 
42. Gonseth J, Guallar-Castillon P, Banegas JR, Rodriguez-Artalejo F. The effectiveness of disease 
management programmes in reducing hospital re-admission in older patients with heart failure: a 
systematic review and meta-analysis of published reports. Eur Heart J. 2004; 25 1570-159. 
43. Bagshaw SM, Stelfox HT, McDermid RC, Rolfson DB, Tsuyuki RT, Baig N, Artiuch B, Ibrahim 
Q, Stollery DE, Rokosh E, Majumdar SM. Association between frailty and short- and long-term 
outcomes among critically ill patients: a multicentre prospective cohort study. CMAJ. 2014; 
186:E96–E102.
44. Dharmarajan K, Masoudi FA, Spertus JA, Li SX, Krumholz HM. Contraindicated initiation of 
beta-blocker therapy in patients hospitalized for heart failure. JAMA Intern Med. 2013; 173:1547–
1549. [PubMed: 23797379] 
45. Jaarsma T, Lesman-Leegte I, Hillege HL, Veeger NJ, Sanderman R, van Veldhuisen DJ. Depression 
and the usefulness of a disease management program in heart failure: insights from the COACH 
(Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure) study. J 
Am Coll Cardiol. 2010; 55:1837–1843. [PubMed: 20413035] 
46. De Jong MJ, Chung ML, Wu JR, Riegel B, Rayens MK, Moser DK. Linkages between anxiety and 
outcomes in heart failure. Heart Lung. 2011; 40:393–404. [PubMed: 21453974] 
47. Whalley B, Rees K, Davies P, Bennett P, Ebrahim S, Liu Z, West R, Moxham T, Thompson DR, 
Taylor RS. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev. 
2011; 8:CD002902.
48. Smeulders ES, van Haastregt JC, Ambergen T, Stoffers HE, Janssen-Boyne JJ, Uszko-Lencer NH, 
Gorgels AP, Lodewijks-van der Bolt CL, van Eijk JT, Kempen GI. Heart failure patients with a 
lower educational level and better cognitive status benefit most from a self-management group 
programme. Patient Educ Couns. 2010; 81:214–221. [PubMed: 20153132] 
49. Heneghan C, Ward A, Perera R. Self-Monitoring Trialist Collaboration. Self-monitoring of oral 
anticoagulation: systematic review and meta-analysis of individual patient data. Lancet. 2012; 
379:322–334. [PubMed: 22137798] 
Jonkman et al. Page 12
Circulation. Author manuscript; available in PMC 2017 March 22.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
Forest plot of effects of self-management interventions on heart failure-related quality of 
life, heart failure-related hospitalization, and all-cause mortality.
CI indicates confidence interval; HR, hazard ratio; and SMD, standardized mean difference.
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Table 1
Baseline characteristics of heart failure patients included in individual patient data meta-analysis.
Control Intervention Total
Sample size, n 2674 2950 5624
Sex
  Male 1505 (56.2) 1711 (58.0) 3126 (57.2)
  Female 1169 (43.7) 1239 (42.0) 2408 (42.8)
Age, y 69.9 ± 12.3 69.6 ± 12.4 69.7 ± 12.4
  <65 years 796 (29.8) 917 (31.1) 1713 (30.5)
  65–80 years 1358 (50.8) 1491 (50.5) 2849 (50.7)
  >80 years 520 (19.4) 542 (18.4) 1062 (18.9)
Systolic dysfunction: LVEF 39.7 ± 18.4 38.7 ± 18.1 39.2 ± 18.2
  >35% LVEF 805 (48.8) 903 (47.3) 1708 (48.0)
  ≤35% LVEF 846 (51.2) 1008 (52.7) 1854 (52.0)
NYHA class
  NYHA I & II 1141 (45.2) 1317 (47.0) 2458 (46.1)
  NYHA III 899 (35.6) 1065 (38.0) 1964 (36.9)
  NYHA IV 484 (19.2) 422 (15.0) 906 (17.0)
Comorbidity index*
  No comorbid conditions 401 (16.7) 556 (20.7) 957 (18.8)
  Comorbid conditions in 1 cluster 925 (38.6) 991 (36.9) 1916 (37.7)
  Comorbid conditions in >1 cluster 1070 (44.7) 1136 (42.3) 2206 (43.4)
Depression†
  No/mild depression 959 (73.9) 1169 (68.8) 2128 (71.0)
  Moderate/severe depression 339 (26.1) 531 (31.2) 870 (29.0)
Level of education
  Primary education or below 807 (42.3) 910 (39.4) 1717 (40.7)
  Secondary education 711 (37.3) 939 (40.6) 1650 (39.1)
  Higher education 388 (20.4) 461 (20.0) 849 (20.1)
Years since diagnosis (median and interquartile range) 2.0 (0.1–6.0) 1.3 (0.1–5.2) 1.6 (0.1–5.4)
  <1 year diagnosed 400 (41.3) 619 (46.2) 1019 (44.1)
  1–2 years diagnosed 118 (12.2) 171 (12.8) 289 (12.5)
  >2 years diagnosed 451 (46.5) 551 (41.1) 1002 (43.4)
Living status
  Living with others 1064 (75.2) 1076 (73.2) 2140 (74.2)
  Living alone 350 (24.8) 393 (26.8) 743 (25.8)
Body mass index 28.2 ± 6.9 27.9 ± 6.4 28.0 ± 6.6
  <25 483 (34.2) 647 (36.1) 1130 (35.3)
  25–29.99 508 (36.0) 611 (34.1) 1119 (35.0)
  ≥30 420 (29.8) 532 (29.7) 952 (29.7)
Smoking status
  Current non-smoker 933 (79.9) 993 (82.1) 1926 (81.1)
Circulation. Author manuscript; available in PMC 2017 March 22.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Jonkman et al. Page 15
Control Intervention Total
  Current smoker 234 (20.1) 216 (17.9) 450 (18.9)
LVEF indicates left ventricular ejection fraction; and NYHA, New York Heart Association.
Values are n(%), mean±SD or median(interquartile range).
*Categories in the present IPD meta-analysis are based on clusters of the Cumulative Illness Rating Scale.20
†
Based on validated cut-off scores of instrument used in each specific study.
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